首页> 外国专利> method for preparation of medicines with anti serotonin, anti histamine, antiemetic and analgesic effect, the formed productand the preparation of the medicines to use active compounds.

method for preparation of medicines with anti serotonin, anti histamine, antiemetic and analgesic effect, the formed productand the preparation of the medicines to use active compounds.

机译:具抗5-羟色胺,抗组胺,止吐镇痛作用的药物的制备方法,所形成的产品以及使用活性化合物的药物的制备。

摘要

1,242,096. Benzo[b]benzofurano[2,3 - e]- oxepines. LABAZ. 3 Dec., 1969 [20 Dec., 1968], No. 60855/68. Heading C2C. Novel benzo[b]benzofurano[2,3-e]oxepines of the general formula wherein R 1 is a #-dimethylaminoethyl, #-dimethylaminoisopropyl, #-piperidinoethyl, #-(4- methylpiperazino)ethyl, (1 - methyl - 2 - piperidyl) - methyl or 1 - methyl - 3 - piperidyl group, R 2 is a hydrogen atom or methyl group, R 3 is a hydrogen or chlorine atom or a methyl or methoxy group, R 4 is a hydrogen atom or methyl group and R 5 is a hydrogen or chlorine atom or a methoxy group, and pharmaceutically acceptable acid addition salts thereof are prepared by reaction of a 6-hydroxybenzo[6]- benzofurano[2,3-e]oxepine of the general formula with a dehydrating agent, followed optionally by salification of the product. 6 - Hydroxy - benzo [b] benzofurano [2,3 - e]- oxepines of the second general formula above are prepared by reaction of an ethyl 3-bromomethyl-coumarilate and a phenol of the respective general formulµ followed by saponification, treatment of the resulting 3 - phenoxymethyl - coumarilic acid of the general formula with thionyl chloride, followed by cyclization and reaction of the resulting 6-oxo-benzo[b]- benzofurano[2,3-e]oxepine of the general formula with a Grignard reagent of the general formula HalMg-CH 2 -R 1 , wherein Hal is a chlorine or bromine atom, followed by hydrolysis. Pharmaceutical compositions having serotonin- and histamine-antagonistic, antalgic and antiemetic activity comprise, as active ingredient, a benzo[b]benzofurano[2,3-e]oxepine of the first general formula above or a pharmaceutically acceptable acid addition salt thereof, together with a pharmaceutical carrier, and may be administered orally, rectally or parenterally.
机译:1,242,096。苯并[b]苯并呋喃并[2,3-e]-奥沙地平。拉巴兹。 1969年12月3日[1968年12月20日],编号60855/68。标题C2C。通式为的新型苯并[b]苯并呋喃并[2,3-e]庚二烯,其中R 1为#-二甲基氨基乙基,#-二甲基氨基异丙基,#-哌啶基乙基,#-(4-甲基哌嗪基)乙基,(1-甲基-2 -哌啶基)-甲基或1-甲基-3-哌啶基,R 2为氢原子或甲基,R 3为氢或氯原子或甲基或甲氧基,R 4为氢原子或甲基,和R 5是氢或氯原子或甲氧基,并且其药学上可接受的酸加成盐通过使通式为6-羟基的苯并[6]-苯并呋喃并[2,3-e]氧杂环庚烷与脱水剂反应来制备。 ,然后可选地将产品盐化。通过使3-溴甲基-香豆酸乙酯与相应的一般配方的酚反应,然后将其皂化,处理,制备上述第二通式的6-羟基-苯并[b]苯并呋喃并[2,3-e]-氧杂环庚烷。得到的通式3-苯氧基甲基-香豆酸与亚硫酰氯,然后环化,得到的通式6-氧代-苯并[b]-苯并呋喃[2,3-e]氧杂庚环与格利雅试剂反应通式HalMg-CH 2 -R 1的化合物,其中Hal是氯或溴原子,然后水解。具有5-羟色胺和组胺拮抗,止痛和止吐活性的药物组合物包含作为活性成分的上述第一通式的苯并[b]苯并呋喃并[2,3-e]奥沙地平或其药学上可接受的酸加成盐与药物载体一起使用,并且可以口服,直肠或肠胃外给药。

著录项

  • 公开/公告号NL6917891A

    专利类型

  • 公开/公告日1970-06-23

    原文格式PDF

  • 申请/专利权人

    申请/专利号NL19690017891

  • 发明设计人

    申请日1969-11-28

  • 分类号C07D21/00;C07D99/04;A61K27/00;

  • 国家 NL

  • 入库时间 2022-08-23 11:33:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号